Meeting
2017 Gastrointestinal Cancers Symposium
The effects of pioglitazone treatment on pancreatic cancer-related insulin resistance.
Authors
Jennifer Stern
UT Southwestern, Dallas, TX
Jennifer Stern , Yull Edwin Arriaga , Arjun Gupta , Udit Verma , Sirisha Karri , Samira K. Syed , Leticia Khosama , John C. Mansour , Philipp Scherer , Muhammad Shaalan Beg
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Translational Research
Clinical Trial Registration Number
NCT01838317
Citation
J Clin Oncol 35, 2017 (suppl 4S; abstract 329)
DOI
10.1200/JCO.2017.35.4_suppl.329
Abstract #
329
Poster Bd #
E21
Abstract Disclosures
Similar Posters
Poster
2017 Gastrointestinal Cancers Symposium
Evaluating associations of diabetes, insulin use, and BMI with efficacy in patients with resected pancreatic cancer: An ancillary analysis of NRG Oncology/RTOG 9704.
First Author: Theodore S. Hong
Poster
2013 ASCO Annual Meeting
The impact of diabetes mellitus and metformin on survival of patients with advanced pancreatic cancer receiving chemotherapy.
First Author: Do-Youn Oh
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Epidemiological characteristics of patients with pancreatic cancer with and without diabetes mellitus: A retrospective cohort study.
First Author: Sarah Elizabeth Eichinger
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Pancreatic cancer and diabetes: The effects of race and genes.
First Author: Michael Shu